Paper Details 
Original Abstract of the Article :
Ten patients with unresectable liver metastases from intraabdominal primary malignancies were treated with combined hepatic irradiation and hepatic artery infusion with FUdR using an Infusaid pump. The median survival for the entire group was 10 months. Four (40%) demonstrated an objective response ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/00000421-199012000-00017

データ提供:米国国立医学図書館(NLM)

Fighting Cancer in the Desert of Metastases

Cancer, a formidable foe, can spread to distant parts of the body, a process known as metastasis. This research focuses on the treatment of liver metastases, a complex challenge. This study examines the use of a combination therapy involving radiation and FUdR, a chemotherapy drug, delivered directly to the liver. The researchers explored the effectiveness of this approach in patients with unresectable liver metastases, meaning the tumors could not be surgically removed.

A Multifaceted Approach to Combating Metastases

The results of this study show that combined hepatic irradiation and hepatic artery infusion with FUdR can be a viable treatment option for patients with unresectable liver metastases.

Combating Cancer's Advance: A Ray of Hope

This research offers a potential pathway to better outcomes for patients with liver metastases. While more research is needed, this study highlights the value of innovative treatment strategies to combat this challenging disease.

Dr.Camel's Conclusion

This research explores a new approach to combating cancer in the desert of metastases. The combined use of radiation and FUdR offers a glimmer of hope for those battling this challenging disease. This study is like a desert oasis, offering a potential refuge for those seeking effective treatment options.

Date :
  1. Date Completed 1990-12-04
  2. Date Revised 2019-09-03
Further Info :

Pubmed ID

2146873

DOI: Digital Object Identifier

10.1097/00000421-199012000-00017

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.